CODX · NASDAQ
Co-Diagnostics (CODX) Stock Price & Fundamentals
Co-Diagnostics (CODX) closed at $917.01 on Oct 9, 2026, up 0.36% from the previous close of $913.68.
Share price, past year
1Y +21.04%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $917.01 |
| Sep 30, 2026 | $899.49 |
| Aug 31, 2026 | $901.06 |
| Jul 31, 2026 | $880.01 |
| Jun 30, 2026 | $851.65 |
| May 29, 2026 | $836.69 |
| Apr 30, 2026 | $878.08 |
| Mar 31, 2026 | $824.51 |
| Feb 27, 2026 | $801.85 |
| Jan 30, 2026 | $774.24 |
| Dec 31, 2025 | $773.43 |
| Nov 28, 2025 | $771.98 |
| Oct 31, 2025 | $753.03 |
Key statistics
- Market cap
- $4.47B
- P/E (TTM)
- —
- EPS (TTM)
- −$12.68
- Revenue (TTM)
- $721.39K
- Net income (TTM)
- −$47.06M
- Shares outstanding
- 4.9M
- Dividend yield
- —
- 52-week range
- $729.48 – $925.72
Co-Diagnostics's market cap is $4.47B, based on a share price of $917.01 and 4.9M shares outstanding as of Jun 30, 2026.
Financials
Co-Diagnostics reported revenue of $622.49K for fiscal 2025, down 84.10% from fiscal 2024.
Co-Diagnostics reported a net loss of $46.90M in fiscal 2025.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2025ended Dec 31, 2025 | $622.49K | −84.1% | −$46.90M | −7,533.6% | −$35.25 | −$29.84M |
| FY2024ended Dec 31, 2024 | $3.92M | −42.5% | −$37.64M | −961.4% | −$37.22 | −$29.90M |
| FY2023ended Dec 31, 2023 | $6.81M | −80.1% | −$35.33M | −518.7% | −$1.20 | −$23.45M |
| FY2022ended Dec 31, 2022 | $34.22M | −65.0% | −$14.24M | −41.6% | −$0.45 | $5.14M |
| FY2021ended Dec 31, 2021 | $97.89M | +31.3% | $36.66M | 37.5% | $1.23 | $40.41M |
| FY2020ended Dec 31, 2020 | $74.55M | +34,579.9% | $42.48M | 57.0% | $1.52 | $27.39M |
| FY2019ended Dec 31, 2019 | $214.97K | +438.6% | −$6.20M | −2,882.0% | −$0.37 | −$5.64M |
| FY2018ended Dec 31, 2018 | $39.91K | +420.9% | −$6.27M | −15,714.3% | — | −$4.12M |
| FY2017ended Dec 31, 2017 | $7.66K | — | −$6.96M | −90,827.9% | — | −$3.34M |
| Quarter | Revenue | Net income | EPS (diluted) |
|---|---|---|---|
| Q2 FY2026ended Jun 30, 2026 | $166.13K | −$6.28M | −$1.46 |
| Q1 FY2026ended Mar 31, 2026 | $145.95K | −$9.14M | −$4.06 |
| Q4 FY2025ended Dec 31, 2025 | $263.92K | −$25.75M | — |
| Q3 FY2025ended Sep 30, 2025 | $145.38K | −$5.89M | −$0.16 |
| Q2 FY2025ended Jun 30, 2025 | $162.91K | −$7.73M | −$7.00 |
| Q1 FY2025ended Mar 31, 2025 | $50.28K | −$7.53M | −$7.05 |
| Q4 FY2024ended Dec 31, 2024 | $149.33K | −$11.03M | — |
| Q3 FY2024ended Sep 30, 2024 | $641.14K | −$9.70M | −$0.32 |
Company profile
- Name
- Co-Diagnostics, Inc.
- Ticker
- CODX
- Exchange
- NASDAQ
- Industry (SEC SIC)
- Surgical & Medical Instruments & Apparatus
- Headquarters
- 2401 S Foothill Drive, Suite D, Salt Lake City, UT 84109
- Incorporated in
- UT
- Fiscal year ends
- December
- SEC CIK
- 0001692415
Recent SEC filings
- Oct 5, 2026
- Sep 25, 2026
- Sep 16, 2026
- Sep 16, 2026
- Sep 15, 2026
- Sep 4, 2026
- Sep 4, 2026
- Aug 13, 2026
Frequently asked questions
What is Co-Diagnostics's stock price?
Co-Diagnostics (CODX) closed at $917.01 on Oct 9, 2026, up 0.36% from the previous close of $913.68.
What is Co-Diagnostics's market cap?
Co-Diagnostics's market cap is $4.47B, based on a share price of $917.01 and 4.9M shares outstanding as of Jun 30, 2026.
How much revenue does Co-Diagnostics make?
Co-Diagnostics reported revenue of $622.49K for fiscal 2025, down 84.10% from fiscal 2024.
Does Co-Diagnostics pay a dividend?
Co-Diagnostics's recent filings report no dividends declared over the last four quarters.
Sources and methodology
Fundamentals come from Co-Diagnostics, Inc.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 8, 2026. Data sources and disclosures